301 related articles for article (PubMed ID: 29895612)
1. Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study.
Warraich HJ; Kaltenbach LA; Fonarow GC; Peterson ED; Wang TY
Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004528. PubMed ID: 29895612
[TBL] [Abstract][Full Text] [Related]
2. Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome).
Fosbøl EL; Ju C; Anstrom KJ; Zettler ME; Messenger JC; Waksman R; Effron MB; Baker BA; Cohen DJ; Peterson ED; Wang TY
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27789517
[TBL] [Abstract][Full Text] [Related]
3. Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Mathews R; Peterson ED; Honeycutt E; Chin CT; Effron MB; Zettler M; Fonarow GC; Henry TD; Wang TY
Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):347-56. PubMed ID: 26038524
[TBL] [Abstract][Full Text] [Related]
4. Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Hess CN; Wang TY; McCoy LA; Messenger JC; Effron MB; Zettler ME; Henry TD; Peterson ED; Fonarow GC
Circulation; 2016 Feb; 133(5):493-501. PubMed ID: 26680241
[TBL] [Abstract][Full Text] [Related]
5. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study.
Fanaroff AC; Kaltenbach LA; Peterson ED; Hess CN; Cohen DJ; Fonarow GC; Wang TY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051217
[TBL] [Abstract][Full Text] [Related]
6. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Anstrom KJ; Fonarow GC; Henry TD; Cannon CP; Choudhry NK; Cohen DJ; Atreja N; Bhalla N; Eudicone JM; Wang TY
Circ Cardiovasc Qual Outcomes; 2020 May; 13(5):e006182. PubMed ID: 32393129
[TBL] [Abstract][Full Text] [Related]
7. Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs.
Doll JA; Kaltenbach LA; Anstrom KJ; Cannon CP; Henry TD; Fonarow GC; Choudhry NK; Fonseca E; Bhalla N; Eudicone JM; Peterson ED; Wang TY
J Am Heart Assoc; 2020 Apr; 9(8):e014975. PubMed ID: 32299284
[TBL] [Abstract][Full Text] [Related]
8. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
[TBL] [Abstract][Full Text] [Related]
9. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
[TBL] [Abstract][Full Text] [Related]
10. CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis.
Jiang M; You JH
Cardiovasc Drugs Ther; 2017 Feb; 31(1):39-49. PubMed ID: 27924429
[TBL] [Abstract][Full Text] [Related]
11. Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.
Baber U; Leisman DE; Cohen DJ; Gibson CM; Henry TD; Dangas G; Moliterno D; Kini A; Krucoff M; Colombo A; Chieffo A; Sartori S; Witzenbichler B; Steg PG; Pocock SJ; Mehran R
Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e004945. PubMed ID: 30606052
[TBL] [Abstract][Full Text] [Related]
12. Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS.
Hess CN; McCoy LA; Duggirala HJ; Tavris DR; O'Callaghan K; Douglas PS; Peterson ED; Wang TY
J Am Heart Assoc; 2014 Feb; 3(1):e000523. PubMed ID: 24510115
[TBL] [Abstract][Full Text] [Related]
13. Magnitude and Characteristics of Patients Who Survived an Acute Myocardial Infarction.
Tisminetzky M; Wang TY; Gurwitz J; Kaltenbach LA; McManus D; Gore J; Peterson E; Goldberg RJ
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28947562
[TBL] [Abstract][Full Text] [Related]
14. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
Mathews R; Wang TY; Honeycutt E; Henry TD; Zettler M; Chang M; Fonarow GC; Peterson ED;
Am Heart J; 2015 Jul; 170(1):62-9. PubMed ID: 26093865
[TBL] [Abstract][Full Text] [Related]
15. Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease.
Rymer JA; Kaltenbach LA; Doll JA; Messenger JC; Peterson ED; Wang TY
J Am Heart Assoc; 2019 May; 8(10):e012236. PubMed ID: 31070112
[TBL] [Abstract][Full Text] [Related]
16. Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry.
Cowper PA; Knight JD; Davidson-Ray L; Peterson ED; Wang TY; Mark DB;
J Am Heart Assoc; 2019 Apr; 8(8):e011322. PubMed ID: 30975005
[TBL] [Abstract][Full Text] [Related]
17. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome.
Ko DT; Krumholz HM; Tu JV; Austin PC; Stukel TA; Koh M; Chong A; de Melo JF; Jackevicius CA
Circ Cardiovasc Qual Outcomes; 2018 Mar; 11(3):e004194. PubMed ID: 29535091
[TBL] [Abstract][Full Text] [Related]
20. Return to Work and Risk of Subsequent Detachment From Employment After Myocardial Infarction: Insights From Danish Nationwide Registries.
Smedegaard L; Numé AK; Charlot M; Kragholm K; Gislason G; Hansen PR
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28978528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
